28.TAXATION

The reconciliation of income taxes at statutory rates with the reported taxes is as follows for the years ended January 31, 2020, 2019 and 2018:

		2020			2019			2018
Loss for the year	$	(28,840,967	)	$	(23,601,170	)	$	(599,471	)
Statutory Tax Rates		27%			27%			26%
Expected income tax (recovery)		(7,787,061	)		(6,372,316	)		(155,863	)
Change in statutory, foreign tax, foreign exchange rates and other		3,135,069			1,297,693			—
Permanent differences		8,006,873			1,494,947			17,156
Share issue costs		(7,590	)		(1,010,208	)		—
Change in unrecognized deductible temporary differences		367,375			4,589,884			138,707
Total income tax expense	$	3,714,666		$	—		$	—

Current income tax expense for the year ended January 31, 2020 is entirely foreign in nature and represents current and deferred taxation arising from business operations in the United States.

The significant components of the Company's deferred tax assets that have not been included on the consolidated statement of financial position are as follows at January 31, 2020, 2019 and 2018:

		2020			2019			2018
Deferred tax assets(liabilities)
Exploration and evaluation assets	$	254,000		$	974,824		$	974,824
Property and equipment		1,012,000			47,452			—
Share issue costs		611,000			809,716			1,550
Biological assets		186,000			58,573			—
Intangible assets		619,000			197,810			—
Marketable securities		2,000			2,325			2,325
Asset retirement obligation		15,000			14,723			14,723
Allowable capital losses		36,000			93,018			56,568
Non-capital losses available for future period		3,918,000			5,241,525			375,052
	$	6,653,000		$	7,439,966		$	1,425,042
Unrecognized deferred tax assets		(6,653,000	)		(7,439,966	)		(1,425,042	)
Net deferred tax assets	$	—		$	—		$	—

The significant components of the Company's temporary differences, unused tax credits and unused tax losses that have not been included in the consolidated statement of financial position are as follows at January 31, 2020, 2019 and 2018:

		2020	Expiry Date Range		2019		2018
Temporary Differences
Exploration and evaluation assets	$	942,000	No expiry date	$	3,611,809	$	3,611,809
Property and equipment		4,819,000	No expiry date		225,963		—
Share issue costs		2,262,000	2038 to 2041		2,998,633		5,424
Biological assets		886,000	No expiry date		278,920		—
Intangible assets		2,949,000	No expiry date		941,954		—
Marketable securities		15,000	No expiry date		15,498		15,498
Asset retirement obligation		54,000	No expiry date		54,243		54,243
Allowable capital losses		135,000	No expiry date		344,223		209,223
Non-capital losses available for future periods		14,511,000	Varies		19,751,990		1,389,396
Canada	$	14,511,000	2026 to 2039	$	18,228,212	$	1,389,396
USA	$	—	No expiry date	$	1,523,778	$	—